Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival
Open Access
- 1 January 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (1) , 146-149
- https://doi.org/10.1038/bjc.1995.30
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityEuropean Journal Of Cancer, 1993
- The relevance of antibody concentration to the immunohistological quantification of cell proliferation‐associated antigensHistopathology, 1993
- Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1Histopathology, 1993
- Growth Fraction in Breast Carcinoma Determined by Ki-67 Immunostaining: Correlation with Pathological and Clinical VariablesGynecologic and Obstetric Investigation, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Hormone sensitivity in breast cancer: Influence of heterogeneity of oestrogen receptor expression and cell proliferationEuropean Journal of Cancer and Clinical Oncology, 1991
- A comparative study of histopathology, hormone receptors, peanut lectin binding, ki-67 immunostaining, and nucleolar organizer region-associated proteins in human breast cancerCancer, 1991
- K-67 Immunoreactivity in Breast Carcinomas in Relation to Transferrin Receptor Expression, Estrogen Receptor Status and Morphological CriteriaOncology, 1989
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Steroid receptors in early breast cancer: Value in prognosisJournal of Steroid Biochemistry, 1981